{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:52:27Z","timestamp":1791337947530,"version":"4.3.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,2,6]],"date-time":"2017-02-06T00:00:00Z","timestamp":1486339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,2,6]],"date-time":"2017-02-06T00:00:00Z","timestamp":1486339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1038\/gt.2017.10","type":"journal-article","created":{"date-parts":[[2017,2,6]],"date-time":"2017-02-06T10:40:49Z","timestamp":1486377649000},"page":"275-281","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["An AAVrh10-CAG-CYP21-HA vector allows persistent correction of 21-hydroxylase deficiency in a Cyp21\u2212\/\u2212 mouse model"],"prefix":"10.1038","volume":"24","author":[{"given":"M","family":"Perdomini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Goumeaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Blouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Bougn\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,6]]},"reference":[{"key":"BFgt201710_CR1","doi-asserted-by":"publisher","first-page":"E28","DOI":"10.1542\/peds.109.2.e28","volume":"109","author":"GA Gmyrek","year":"2002","unstructured":"Gmyrek GA, New MI, Sosa RE, Poppas DP . Bilateral laparoscopic adrenalectomy as a treatment for classic congenital adrenal hyperplasia attributable to 21-hydroxylase deficiency. Pediatrics 2002; 109: E28.","journal-title":"Pediatrics"},{"key":"BFgt201710_CR2","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1210\/jcem.86.2.7208","volume":"86","author":"H Bruining","year":"2001","unstructured":"Bruining H, Bootsma AH, Koper JW, Bonjer J, de Jong FH, Lamberts SWJ . Fertility and body composition after laparoscopic bilateral adrenalectomy in a 30-year-old female with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2001; 86: 482\u2013484.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFgt201710_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2010\/670960","volume":"2010","author":"KJ Loechner","year":"2010","unstructured":"Loechner KJ, McLaughlin JT, Calikoglu AS . Alternative strategies for the treatment of classical congenital adrenal hyperplasia: pitfalls and promises. Int J Pediatr Endocrinol 2010; 2010: 1\u201310.","journal-title":"Int J Pediatr Endocrinol"},{"key":"BFgt201710_CR4","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1210\/jc.2006-1757","volume":"92","author":"F Gastaud","year":"2007","unstructured":"Gastaud F, Bouvattier C, Duranteau L, Brauner R, Thibaud E, Kutten F et al. Impaired sexual and reproductive outcomes in women with classical forms of congenital adrenal hyperplasia. J Clin Endocrinol Metab 2007; 92: 1391\u20131396.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFgt201710_CR5","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1210\/en.2004-1563","volume":"146","author":"FG Riepe","year":"2005","unstructured":"Riepe FG, Tatzel S, Sippell WG, Pleiss J, Krone N . Congenital adrenal hyperplasia: the molecular basis of 21-hydroxylase deficiency in H-2(aw18) mice. Endocrinology 2005; 146: 2563\u20132574.","journal-title":"Endocrinology"},{"key":"BFgt201710_CR6","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1210\/endo.140.7.6755","volume":"140","author":"T Tajima","year":"1999","unstructured":"Tajima T, Ma XM, Bornstein SR, Aguilera G . Prenatal dexamethasone treatment does not prevent alterations of the hypothalamic pituitary adrenal axis in steroid 21-hydroxylase deficient mice. Endocrinology 1999; 140: 3354\u20133362.","journal-title":"Endocrinology"},{"key":"BFgt201710_CR7","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1096\/fasebj.13.10.1185","volume":"13","author":"SR Bornstein","year":"1999","unstructured":"Bornstein SR, Tajima T, Eisenhofer G, Haidan A, Aguilera G . Adrenomedullary function is severely impaired in 21-hydroxylase-deficient mice. FASEB J 1999; 13: 1185\u20131194.","journal-title":"FASEB J"},{"key":"BFgt201710_CR8","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1038\/sj.gt.3301018","volume":"6","author":"T Tajima","year":"1999","unstructured":"Tajima T, Okada T, Ma XM, Ramsey W, Bornstein S, Aguilera G . Restoration of adrenal steroidogenesis by adenovirus-mediated transfer of human cytochromeP450 21-hydroxylase into the adrenal gland of21-hydroxylase-deficient mice. Gene Therapy 1999; 6: 1898\u20131903.","journal-title":"Gene Therapy"},{"key":"BFgt201710_CR9","unstructured":"Macapagal MC, Slowinska BS, Nimkarn S, De BP, Licholai T, MI et al Gene therapy of 21-hydroxylase deficient mice utilizing an adeno-associated virus vector. Abstract the Endocrine Society\u2019s 84th Annual Meeting, San Francisco, 2002, pp 1\u2013503."},{"key":"BFgt201710_CR10","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1507\/endocrj.EJ16-0112","volume":"63","author":"Y Naiki","year":"2016","unstructured":"Naiki Y, Miyado M, Horikawa R, Katsumata N, Onodera M, Pang S et al. Extra-adrenal induction of Cyp21a1 ameliorates systemic steroid metabolism in a mouse model of congenital adrenal hyperplasia. Endocr J 2016; 63: 897\u2013904.","journal-title":"Endocr J"},{"key":"BFgt201710_CR11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s40778-014-0001-1","volume":"1","author":"IE Alexander","year":"2015","unstructured":"Alexander IE, Russell DW . The potential of AAV-mediated gene targeting for gene and cell therapy applications. Curr Stem Cell Rep 2015; 1: 16\u201322.","journal-title":"Curr Stem Cell Rep"},{"key":"BFgt201710_CR12","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/gt.2014.103","volume":"22","author":"R Thwaite","year":"2015","unstructured":"Thwaite R, Pag\u00e8s G, Chill\u00f3n M, Bosch A . AAVrh.10 immunogenicity in mice and humans. Relevance of antibody cross-reactivity in human gene therapy. Gene Therapy 2015; 22: 196\u2013201.","journal-title":"Gene Therapy"},{"key":"BFgt201710_CR13","first-page":"119","volume-title":"AAV Biology, Infectivity and Therapeutic Use from Bench to Clinic Gene Therapy\u2014Principles and Challenges","author":"MA Vance","year":"2015","unstructured":"Vance MA, Mitchell A, Samulski RJ . AAV Biology, Infectivity and Therapeutic Use from Bench to Clinic Gene Therapy\u2014Principles and Challenges, Chapter 5 InTech, 2015, pp 119\u2013143."},{"key":"BFgt201710_CR14","doi-asserted-by":"publisher","first-page":"7860","DOI":"10.1073\/pnas.82.23.7860","volume":"82","author":"KL Parker","year":"1985","unstructured":"Parker KL, Chaplin DD, Wong M, Seidman JG, Smith JA, Schimmer BP . Expression of murine 21-hydroxylase in mouse adrenal glands and in transfected Y1 adrenocortical tumor cells. Proc Natl Acad Sci USA 1985; 82: 7860\u20137864.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201710_CR15","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S0896-6273(00)80491-2","volume":"20","author":"GW Smith","year":"1998","unstructured":"Smith GW, Aubry JM, Dellu F, Contarino A, Bilezikjian LM, Gold LH et al. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 1998; 20: 1093\u20131102.","journal-title":"Neuron"},{"key":"BFgt201710_CR16","doi-asserted-by":"publisher","first-page":"6243","DOI":"10.1523\/JNEUROSCI.0736-05.2005","volume":"25","author":"S Ridder","year":"2005","unstructured":"Ridder S, Chourbaji S, Hellweg R, Urani A, Zacher C, Schmid W et al. Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions. J Neurosci 2005; 25: 6243\u20136250.","journal-title":"J Neurosci"},{"key":"BFgt201710_CR17","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/74263","volume":"24","author":"TL Bale","year":"2000","unstructured":"Bale TL, Contarino A, Smith GW, Chan R, Gold LH, Sawchenko PE et al. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet 2000; 24: 410\u2013414.","journal-title":"Nat Genet"},{"key":"BFgt201710_CR18","doi-asserted-by":"publisher","first-page":"14488","DOI":"10.1073\/pnas.97.26.14488","volume":"97","author":"ML Bland","year":"2000","unstructured":"Bland ML, Jamieson CAM, Akana SF, Bornstein SR, Eisenhofer G, Dallman MF et al. Haploinsufficiency of steroidogenic factor-1 in mice disrupts adrenal development leading to an impaired stress response. Proc Natl Acad Sci USA 2000; 97: 14488\u201314493.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201710_CR19","first-page":"55","volume":"21","author":"RM Sapolsky","year":"2000","unstructured":"Sapolsky RM, Romero LM, Munck AU . How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 2000; 21: 55\u201389.","journal-title":"Endocr Rev"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt201710.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201710","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/gt.2017.10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/gt201710.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T09:22:39Z","timestamp":1648545759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt201710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,6]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["BFgt201710"],"URL":"https:\/\/doi.org\/10.1038\/gt.2017.10","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727280916.793558230","asserted-by":"object"}]},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,6]]},"assertion":[{"value":"24 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}